Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Income Opportunity Realty Investors Shareholder Meeting
Income Opportunity Realty Investors held its Annual Meeting of Stockholders on November 11, 2026, where shareholders elected four directors to the board and ratified the appointment of Farmer, Fuqua & Huff, P.C. as the independent auditor for fiscal year 2026. Following the meeting, the board re-elected Henry A. Butler as Chairman and re-appointed Ted Munselle as Presiding Director.
AtlasClear Holdings, Inc. reported financial results for the fiscal quarter and nine months ended September 30, 2026, including the condensed consolidated financial statements of Autonomous Power Corporation. The company reported total revenues of $9.14 million and a net loss of $32.83 million for the nine-month period ended September 30, 2026.
Powerus M&A Deal with Autonomous Power Corporation
Powerus Corporation filed historical and pro forma financial statements related to its completed merger with Autonomous Power Corporation (Legacy Powerus). The merger, which closed on October 1, 2026, resulted in Legacy Powerus becoming a direct subsidiary of the company.
Aclaris Therapeutics announced that its Phase 2 ADMIRATION trial of bosakitug (ATI-045) for moderate-to-severe atopic dermatitis failed to meet its primary and secondary endpoints. Despite robust target engagement and biomarker downregulation, the company will shift focus toward its oral ITK inhibitors and bispecific antibody ATI-052. The company also announced the initiation of a Phase 2b trial for modzatinib in lichen planus and plans to file an IND for ATI-9494 in Q4 2026.
Vir Biotechnology entered into an underwriting agreement to sell 15,000,000 shares of common stock at a public offering price of $10.00 per share. The company expects to receive approximately $140.4 million in net proceeds, or $161.5 million if the underwriters exercise their 30-day option to purchase an additional 2,250,000 shares.
Henry Schein announced a voluntary change to its non-GAAP financial reporting to exclude acquisition-related remeasurement gains starting in Q4 2026. Consequently, the company updated its FY2026 non-GAAP diluted EPS guidance to $5.42-$5.48 from $5.50-$5.56 to reflect this accounting adjustment, with no change to its underlying business outlook.
22nd Century Group reported third quarter 2026 revenue of $4.8 million, a 66% sequential increase, and achieved positive gross profit of $0.4 million. The company highlighted significant retail expansion for its Pinnacle VLN and Pinnacle Pure cigarette products, including a new distribution partnership with Gopuff. Management also noted a simplified capital structure following the redemption of Series B preferred stock and the elimination of outstanding warrants.
Term
Q3 2026
“The third quarter marked a period of accelerating commercial execution featuring expanded market adoption of our Pinnacle branded products. We grew revenue 66% sequentially to $4.8 million, turned gross profit positive, and meaningfully reduced our operating loss, all while continuing to expand retail distribution, increase consumer awareness and strengthen the commercial foundation for our VLN® products.”
Larry Firestone, Chief Executive Officer of 22nd Century Group
“Alongside this commercial progress, we significantly cleaned up our capital structure. Following quarter-end, we raised $5.8 million of net cash proceeds through an at-the-market offering, used $1.2 million of those proceeds to redeem an equal amount of our Series B convertible preferred stock at par, and enter the fourth quarter with no warrants outstanding.”
Larry Firestone, Chief Executive Officer of 22nd Century Group
Rezolute, Inc. entered into an underwriting agreement for a public offering of 22,040,976 shares of common stock and 3,800,000 pre-funded warrants, expected to raise gross proceeds of approximately $100 million. The financing was led by Frazier Life Sciences and is intended to fund commercialization preparation for ersodetug and general corporate purposes.
Biohaven Ltd. is delivering an investor presentation at the Jefferies Global Healthcare Conference in London from November 16-19, 2026. The presentation provides a corporate update on the company's clinical pipeline, including programs in glutamate modulation, immunology, and oncology.
Silexion Therapeutics reported Q3 2026 financial results, highlighting the dosing of the first patient in its Phase 2/3 clinical trial of SIL204 for pancreatic cancer. The company strengthened its balance sheet through a public offering and warrant inducement, ending the quarter with $4.8 million in cash and $3.0 million in shareholders' equity.
Term
Q3 2026
“In the third quarter, we began treating patients with SIL204 in our Phase 2/3 trial in pancreatic cancer. After opening our first clinical site at Tel Aviv Sourasky Medical Center in July, we dosed the first patient at the end of September. At the same time, our laboratory work continued to strengthen the case for SIL204, with new data suggesting it may help the immune system recognize cancer cells, and showing that it uses natural carriers in the blood to enter cancer cells. Our focus now is on enrolling the first group of patients and bringing more hospitals in Israel and Germany into the trial.”
Ilan Hadar, Chairman and Chief Executive Officer
“During the third quarter, we completed a public offering and a warrant inducement transaction and continued sales under our at-the-market facility, increasing our cash and cash equivalents to $4.8 million and shareholders’ equity to approximately $3.0 million as of September 30, 2026. This financial progress strengthens our balance sheet and supports the continued advancement of SIL204 as we enroll patients in the Phase 2/3 trial.”
KALA BIO received a determination from the Nasdaq Hearings Panel granting its request to continue its listing on The Nasdaq Capital Market subject to specific conditions. The company must evidence a closing bid price of at least $1.00 per share for ten consecutive business days by November 30, 2026, and maintain that price through February 23, 2027. Failure to meet these conditions or any other listing rules during this period may result in delisting.
DataMEDS AI, Inc. entered into an at-the-market (ATM) sales agreement with Dawson James Securities, Inc. to establish an offering program for its common stock. The company may sell shares from time to time at prevailing market prices, though it is not obligated to make any sales. The Sales Agent will receive a fixed commission of 3.0% of the gross proceeds from any shares sold.
T. Rowe Price OHA Select Private Credit Fund Dividend
T. Rowe Price OHA Select Private Credit Fund declared total distributions of $0.60 per share for the third quarter of 2026, representing an annualized distribution rate of 9.2%. The fund reported net investment income of $0.60 per share and a net asset value (NAV) of $26.02 per share as of September 30, 2026.
For the nine months ended September 30, 2026, OHA Senior Private Lending Fund reported a significant decrease in net increase in net assets resulting from operations to $0.29 million, down from $73.96 million in the prior year period, primarily driven by a $26.02 million net unrealized depreciation. Total investment income also saw a decline to $31.00 million compared to $34.62 million in 2025.
Origin Tea Inc. reported $0 revenue for fiscal 2026 as it transitioned from no operations to establishing tea procurement and distribution infrastructure. The company reported a net loss of $54,140 and a working capital deficit of $100,287, leading to a going concern qualification from its auditors.
For the nine months ended September 30, 2026, the Fund reported total investment income of $230.5 million and net investment income of $111.6 million. Total net assets stood at $1.63 billion with a net asset value per share of $26.02 across all classes, reflecting a decrease from $26.89 at the end of 2025.
ESG Inc. completed a split-off of its China operations on May 26, 2026, resulting in a significant reduction in total assets from $26.9 million to $145,551. The company reported a net loss of $1.1 million for the nine months ended September 30, 2026, and management has expressed substantial doubt about its ability to continue as a going concern due to limited revenue and a working capital deficit.
Research Alliance Corp III is a blank check company that entered into a Business Combination Agreement with OHBP on July 26, 2026, with an expected closing in Q4 2026. The company reported a backstop liability of $1,687,399 as of September 30, 2026, and recently secured a $3,000,000 working capital loan from its Sponsor to fund transaction expenses.
Sky Quarry Inc. reported a significant decrease in net sales to $30,528 for the nine months ended September 30, 2026, compared to $12.2 million in the prior year, resulting in a net loss of $10.3 million. Despite the operational loss, the company significantly strengthened its cash position to $3.76 million through common stock subscriptions totaling over $13.9 million.
Hawaiian Electric Industries Investor Presentation
Hawaiian Electric Industries (HEI) filed a formal investor presentation for meetings beginning November 16, 2026, detailing its strategic recovery following the 2023 Maui wildfires. The presentation highlights significant de-risking milestones, including a court-approved global settlement, rebuilt liquidity of approximately $1.3 billion, and the transition to a pure-play utility model.
Callan JMB Inc. reported a net loss of $7.18 million for the nine months ended September 30, 2026, compared to a $5.37 million loss in the prior year period, driven by a 20% decline in revenue and significant ELOC facility transaction expenses. The company's cash position decreased to $1.78 million as it continues to rely on equity line of credit (ELOC) financing and a $1.0 million line of credit to fund operations.
TOMI Environmental Solutions reported preliminary Q3 2026 results, highlighting a 24% year-over-year revenue increase to $2.49 million and a return to positive operating income of $30,000. The company noted that full GAAP results, including net loss and EPS, are pending a final accounting review of the conversion of $2.5 million in convertible notes during the quarter.
American Picture House Corp reported a net loss of $349,421 for the nine months ended September 30, 2026, a significant improvement from the $1,355,022 loss in the prior year period. The company remains in a deficit position with a total stockholders' deficit of $476,364 and reported minimal revenue of $1,220 for the year-to-date period.
CorMedix Inc. announced a definitive agreement to acquire substantially all of the assets of Heron Therapeutics, Inc., including both commercial and pipeline assets. The acquisition is intended to provide scale and diversification to CorMedix's institutional care growth strategy and remains subject to Heron stockholder approval and regulatory clearance.
For the three months ended September 30, 2026, APPlife Digital Solutions reported a net loss of $1,129,902 on revenue of $195,575, a significant decline from the $96,322 net income reported in the prior year period. The loss was driven by a substantial increase in other expenses, specifically a $422,958 change in the fair value of derivative liabilities and $256,169 in debt discount amortization.
NEXGEL, INC. reported a net loss of $5.68 million for the nine months ended September 30, 2026, compared to $2.03 million in the prior year, driven by significant increases in selling, general, and administrative expenses. Total assets grew to $23.90 million following a major $12.34 million increase in intangible assets, while the company underwent a 1-for-20 reverse stock split in October 2026.
For the nine months ended September 30, 2026, Apollo Infrastructure Co LLC reported total investment income of $56.1 million, driven by $41.7 million in interest income and $14.3 million in dividends. Total net assets grew to $2.196 billion as of September 30, 2026, compared to $1.736 billion at the end of 2025, supported by significant investment activity and the utilization of a $380 million credit facility.
For the nine months ended September 30, 2026, KKR Enhanced US Direct Lending Fund-L Inc. reported total investment income of $95.8 million and net investment income of $62.1 million. Net assets grew to $857.5 million, driven by $169.5 million in subscriptions, though net asset value per share decreased from $1,031.53 to $1,002.25 during the period.
Ministry Partners Investment Company, LLC reported a net loss of $843 thousand for the nine months ended September 30, 2026, compared to a net income of $195 thousand in the prior year period. The decline was driven by lower interest income on loans and a significant increase in salaries and benefits expenses.
Armlogi Holding Corp. reported a net loss of $4.1 million for the quarter ended September 30, 2026, an improvement from the $6.5 million loss in the prior year period. Revenue decreased to $36.9 million from $49.5 million, though the company achieved a positive gross profit of $0.9 million compared to a gross loss in 2025.